Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Perin

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Leukemia & Lymphoma|April 28, 2000
Primary effusion lymphoma cell lines harbouring human herpesvirus type-8A Carbone, A M Cilia, A Gloghini, et al.
International Journal of Cancer|December 6, 1997
Establishment of HHV-8-positive and HHV-8-negative lymphoma cell lines from primary lymphomatous effusionsA Carbone, A M Cilia, A Gloghini, et al.
Blood|May 15, 1997
Reed-Sternberg cells of classical Hodgkin's disease react with the plasma cell-specific monoclonal antibody B-B4 and express human syndecan-1A Carbone, A Gloghini, V Gattei, et al.
Genes, Chromosomes & Cancer|January 19, 1999
Genetic characterization of HHV-8/KSHV-positive primary effusion lymphoma reveals frequent mutations of BCL6: implications for disease pathogenesis and histogenesisG Gaidano, D Capello, A M Cilia, et al.
Leukemia|July 29, 2000
Characterization of a novel HHV-8-positive cell line reveals implications for the pathogenesis and cell cycle control of primary effusion lymphomaA Carbone, A M Cilia, A Gloghini, et al.
Blood|January 7, 1998
Association of Kaposi's sarcoma-associated herpesvirus-positive primary effusion lymphoma with expression of the CD138/syndecan-1 antigenG Gaidano, A Gloghini, V Gattei, et al.
Journal of Translational Medicine|June 28, 2015
Improved Natural Killer cell activity and retained anti-tumor CD8(+) T cell responses contribute to the induction of a pathological complete response in HER2-positive breast cancer patients undergoing neoadjuvant chemotherapyE Muraro, E Comaro, R Talamini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 2008
Thymidine phosphorylase expression is associated with time to progression in patients receiving low-dose, docetaxel-modulated capecitabine for metastatic breast cancerF Puglisi, G G Cardellino, D Crivellari, et al.
Leukemia & Lymphoma|August 28, 1998
BCL-6 in aids-related lymphomas: pathogenetic and histogenetic implicationsG Gaidano, D Capello, A Gloghini, et al.
Oncogene|February 16, 2016
Radiotherapy-induced miR-223 prevents relapse of breast cancer by targeting the EGF pathwayL Fabris, S Berton, F Citron, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Leukemia & Lymphoma|April 28, 2000
Primary effusion lymphoma cell lines harbouring human herpesvirus type-8A Carbone, A M Cilia, A Gloghini, et al.
International Journal of Cancer|December 6, 1997
Establishment of HHV-8-positive and HHV-8-negative lymphoma cell lines from primary lymphomatous effusionsA Carbone, A M Cilia, A Gloghini, et al.
Blood|May 15, 1997
Reed-Sternberg cells of classical Hodgkin's disease react with the plasma cell-specific monoclonal antibody B-B4 and express human syndecan-1A Carbone, A Gloghini, V Gattei, et al.
Genes, Chromosomes & Cancer|January 19, 1999
Genetic characterization of HHV-8/KSHV-positive primary effusion lymphoma reveals frequent mutations of BCL6: implications for disease pathogenesis and histogenesisG Gaidano, D Capello, A M Cilia, et al.
Leukemia|July 29, 2000
Characterization of a novel HHV-8-positive cell line reveals implications for the pathogenesis and cell cycle control of primary effusion lymphomaA Carbone, A M Cilia, A Gloghini, et al.
Blood|January 7, 1998
Association of Kaposi's sarcoma-associated herpesvirus-positive primary effusion lymphoma with expression of the CD138/syndecan-1 antigenG Gaidano, A Gloghini, V Gattei, et al.
Journal of Translational Medicine|June 28, 2015
Improved Natural Killer cell activity and retained anti-tumor CD8(+) T cell responses contribute to the induction of a pathological complete response in HER2-positive breast cancer patients undergoing neoadjuvant chemotherapyE Muraro, E Comaro, R Talamini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 2008
Thymidine phosphorylase expression is associated with time to progression in patients receiving low-dose, docetaxel-modulated capecitabine for metastatic breast cancerF Puglisi, G G Cardellino, D Crivellari, et al.
Leukemia & Lymphoma|August 28, 1998
BCL-6 in aids-related lymphomas: pathogenetic and histogenetic implicationsG Gaidano, D Capello, A Gloghini, et al.
Oncogene|February 16, 2016
Radiotherapy-induced miR-223 prevents relapse of breast cancer by targeting the EGF pathwayL Fabris, S Berton, F Citron, et al.
Pageof 2